With increasing focus on the link between infectious disease and poverty in the developing world, there is a commensurate effort to develop better mobile alternatives to infectious disease detection contributing to improved global health. Faster diagnosis of acute infection at the Point-of-Care (PoC) is needed in both inpatient and outpatient settings largely contributing for the global attempt to reduce antimicrobial resistance (AMR), with a rate of inappropriate antibiotic prescription at 30-50%. Thus, there is a growing need for an early and accurate POC infection diagnosis solution that collects, stores and integrates the spatially distributed bacterial/viral mutations that affect billions of lives.
Current PoC technology presents numerous issues due to the lack of connectivity, which inhibits success and economic impact. Enabling connectivity to lab-on-a-chip devices can have a dual impact on the performance of the system; 1) Offloading the biomarkers data processing to the cloud can increase their analysis with enhanced computational power using correlated multivariable analysis with data mining technique; 2) the infection data is collected real-time from different GPs can be analyzed with a geographical distribution, which can assess the infection distribution behavior in the society.
The Clinical Data as a Service Platform (CDaaS) will be developed to bring to GPs, surgeons and third parties, synthetized information of PoC diagnosis data, specifically in this case for the detection of acute infection with the identification of either bacterial or viral causes. This solution focuses on extending the market around lab-on-a-chip devices while enabling the creation of a mobile application that can assist medical doctor in assessing the causes of infection at the PoC. Furthermore, this diagnostic data will be incorporated into a sensitive geographical infection analysis, which identifies potentially fast-emerging infection sites in real time. This enhanced flexibility, accessibility and performance will push this technology further creating a massive economic and medical impact around the world.